What is CVKD's dilution risk score?

CVKD has a latest available DilutionScore record of 71/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for CVKD, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for CVKD?

DilutionWatch tracks 25 SEC filing types for CVKD including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect CVKD shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For CVKD, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for CVKD tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for CVKD. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

CVKD Dilution Risk Score: 71/100 (HIGH)

Score Breakdown

📋 Offering Ability

72

💰 Cash Runway

95

📊 Float Risk

30

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 30%

💰 Capital Raise model 55%

• Critical: only 2.6 months cash remaining

📉 Score Deterioration model 10%

• Score in HIGH risk zone (71/100)

🔔 Track CVKD — Get forecast alerts →

Market Data

Market Cap$15.27M

Shares Outstanding3.57M

Float2.38M

Cash$2.39M

Debt$597.1K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 13.9% shares (2026Q1 vs prior)

17 institutional holders · 138.4K shares

#1 VANGUARD CAPITAL MANAGEMENT LLC 90.4K shares

#2 GEODE CAPITAL MANAGEMENT, LLC 21.6K shares

#3 VANGUARD FIDUCIARY TRUST CO 8.3K shares

+ 14 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest61.1K

Days to Cover1.2

% of Float2.6%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-09-30

xbrl XBRL CONVERTIBLE 2023-12-31

EFFECT EFFECT 2026-04-29

424B3 ATM 2026-04-29

S-3 SHELF 2026-04-21

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual CVKD Dilution Snapshot

Cadrenal Therapeutics, Inc. (CVKD) has a DilutionScore of 71/100, rated High dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for CVKD: EFFECT on 2026-04-29; 424B3 on 2026-04-29; S-3 on 2026-04-21.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.